Learn more about our upcoming Galas and Signature Events Learn More
Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...
The Melanoma Research Foundation Applauds the Senate for Unanimous Approval of Sunscreen Innovation Act Act Will Expedite FDA Review of New Sunscreen Filters, Providing Con...
The MRF is pleased to announce its 2014 melanoma research grant awardees!
The Senate is seeking public comments regarding the Sunscreen Innovation Act. Comments are due by COB Friday, August 29th, 2014.
USA Today reporter Kim Painter wrote about the Surgeon General's Call to Action to Prevent Skin Cancer. In her article, titled "Surgeon General: Stop tanning and s...
Associated Press reporter Anne Flaherty summarized the recent Call to Action to Prevent Skin Cancer, issued by Surgeon General Boris Lushniak in her article titled. The MRF...
The Surgeon General issued a Call to Action regarding skin cancer prevention efforts, recognizing the need for effective action in decreasing the rates of melanoma.
The Melanoma Research Foundation Applauds the House of Representatives for Swift Approval of Sunscreen Innovation Act Act Will Expedite FDA Review of New Sunscreen Filters,...
The Senate Appropriations Committee approved their fiscal year 2015 Defense Appropriations bill which includes $50 million for the Department of Defense’s (DoD) Peer ...
Justin Beiber may be saving lives with his hairdo. I never thought I’d ever type those words but there might be something to that statement. According to this ...
Senator Jack Reed (D-RI), Senator Johnny Isakson (R-GA), Congressman Ed Whitfield (R-KY) and Congressman John Dingell (D-MI) recently introduced the Sunscreen Innovation Ac...
Researchers at the University of California San Diego School of Medicine recently discovered a therapeutic target for treating ocular melanoma to potentially stop its growt...
Statement from Tim Turnham, Executive Director, Melanoma Research Foundation, Regarding Ipilimumab as Adjuvant Therapy for Melanoma Today Bristol-Meyers Squibb (BMS) announ...
Jul 15, 2025 ET
